Hematology/Oncology

Top Story

Cytogenetic, molecular factors predict prognosis among patients who relapse after allogeneic HSCT

Cytogenetic, molecular factors predict prognosis among patients who relapse after allogeneic HSCT
February 22, 2020
Meeting News

KTE-X19 induces durable responses in relapsed, refractory mantle cell lymphoma

February 22, 2020
ORLANDO — A single infusion of KTE-X19 induced high rates of durable response among patients with relapsed or refractory mantle cell lymphoma, according to results…
Meeting NewsPerspective

Off-the-shelf CAR T-cell therapy induces durable remissions in relapsed, refractory B-cell malignancies

February 21, 2020
ORLANDO — Off-the-shelf chimeric antigen receptor T-cell therapy induced durable remissions among patients with relapsed or refractory B-cell malignancies…
Meeting News

Acute GVHD less severe after haploidentical transplant with post-cyclophosphamide prophylaxis

February 21, 2020
ORLANDO — Acute graft-versus-host disease tended to be less severe among patients who underwent haploidentical transplantation with post-cyclophosphamide…
In the Journals

Lifetime prevalence of skin cancer higher in gay, bisexual men

February 21, 2020
Self-reported lifetime prevalence of skin cancer was higher in gay and bisexual men compared with heterosexual men, according to a cross-sectional study published in…
More Headlines »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next